OMBCL Shorts #1: Dr. Stephanie Graff & Her Steps For Those Newly Diagnosed MBC
Medical Community, Diagnosis and Treatment, Newly Diagnosed Our MBClife Medical Community, Diagnosis and Treatment, Newly Diagnosed Our MBClife

OMBCL Shorts #1: Dr. Stephanie Graff & Her Steps For Those Newly Diagnosed MBC

Our inaugural OMBCL Shorts features Dr. Stephanie Graff talking about what she does when someone is newly diagnosed with MBC. This season, we had a 3-part series for people newly diagnosed and we couldn't resist getting her take on the topic. And we're so glad we asked!

Read More
ASCO 2022: When The Dust Settles, What Are My Treatment Options For ER+/HER2- MBC?
Novel Treatments, Medical Community, Diagnosis and Treatment, Clinical Research, Updates from Conferences, Entities of Cancer Our MBClife Novel Treatments, Medical Community, Diagnosis and Treatment, Clinical Research, Updates from Conferences, Entities of Cancer Our MBClife

ASCO 2022: When The Dust Settles, What Are My Treatment Options For ER+/HER2- MBC?

Welcome to the second part of our post–2022-ASCO analysis of the state of affairs in the HR-positive MBC. It was not so long ago that our only options were single-agent endocrine therapy and systemic chemo. We have come a long way over the last couple of decades. Today we are asking Drs. Stephanie Graff, Sara Hurvitz, and Kevin Kalinsky to talk about how they make decisions in the clinic in selecting and sequencing treatments, specifically CDK4/6 inhibitors and the newly approved targeted therapies.

Read More
ASCO 2022: When the Dust Settles, Will ADCs Change MBC?
Novel Treatments, Clinical Research, Medical Community, Entities of Cancer, Diagnosis and Treatment, Difficult to Treat, Updates from Conferences Our MBClife Novel Treatments, Clinical Research, Medical Community, Entities of Cancer, Diagnosis and Treatment, Difficult to Treat, Updates from Conferences Our MBClife

ASCO 2022: When the Dust Settles, Will ADCs Change MBC?

While HER2-Low and DESTINY-Breast04 garnered most of the headlines from the ASCO 2022 in June, it was not the only reason for optimism. Our MBC Life takes a deeper dive with Dr. Stephanie Graff and Dr. Hope Rugo in this first episode of our two-part series.

Read More
Dr. Stephanie Graff: Understanding Progression
Essential Knowledge, Medical Community, Challenges and Barriers, MBC Imaging and Profiling, Difficult to Treat, Novel Treatments, Obstacles to Better Outcomes, Diagnosis and Treatment, Entities of Cancer Our MBClife Essential Knowledge, Medical Community, Challenges and Barriers, MBC Imaging and Profiling, Difficult to Treat, Novel Treatments, Obstacles to Better Outcomes, Diagnosis and Treatment, Entities of Cancer Our MBClife

Dr. Stephanie Graff: Understanding Progression

What does it mean when our cancer shows progression? And how do we know when that happens? The Our MBC Life team gets the lowdown from Dr. Stephanie L. Graff.

Read More